Protagonist Therapeutics, Inc (PTGX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for PTGX. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 9,779,369 | $1.0B | INCREASED |
| FARALLON CAPITAL MANAGEMENT LLC | 6,348,906 | $669M | INCREASED |
| UBS Group AG | 5,177,796 | $546M | INCREASED |
| RTW INVESTMENTS, LP | 5,059,053 | $533M | UNCHANGED |
| WELLINGTON MANAGEMENT GROUP LLP | 3,599,644 | $379M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| William D. Waddill (Director) | EXERCISE | 6,000 | $99K | 2026-06-10 |
| William D. Waddill (Director) | EXERCISE | 3,000 | $35K | 2026-06-10 |
| William D. Waddill (Director) | SELL | 9,000 | $969K | 2026-06-10 |
| William D. Waddill (Director) | EXERCISE | 9,000 | $106K | 2026-05-29 |
| William D. Waddill (Director) | SELL | 9,000 | $897K | 2026-05-29 |
Full institutional holdings, insider history, and congressional trades for Protagonist Therapeutics, Inc on SentiSense.